Mortalin showed a mainly cytoplasmic staining pattern in breast cancers and the strongly positive rate of mortalin was in 64% of invasive ductal carcinoma of breast and was significantly higher than in 34.6% of DCIS and 15.6% of adjacent non-tumor tissues. This evidence concerns the gene HSPA9 and invasive ductal breast carcinoma.